EMA
approval
· 2020-10-16
First CAR-T cell medicine for mantle cell lymphoma
Summary
The EMA announces the first CAR-T cell medicine approved for mantle cell lymphoma, marking a milestone in targeted cellular therapy for this indication.
Upgrade for the full analysis, importance score, and drug timeline.